PreciControl HBsAg II - Hepatitis B virus surface antigen IVD, control

Država: Avstralija

Jezik: angleščina

Source: Department of Health (Therapeutic Goods Administration)

Kupite ga zdaj

Javno poročilo o oceni Javno poročilo o oceni (PAR)
22-11-2017

Dostopno od:

Roche Diagnostics Australia Pty Limited

Razred:

Class 4

Izdeluje:

Roche Diagnostics GmbH Sandhofer Strasse 116, Mannheim, D-68305 Germany

Terapevtsko območje:

42000 - Hepatitis B virus surface antigen IVD, control

Terapevtske indikacije:

A ready to use control serum based on human serum both in the negative and positive concentration range. For quality control of the Elecsys HBsAg II and Elecsys HBsAg II Auto Confirm immunoassays on the Elecsys and cobas e immunoassay analysers.

Status dovoljenje:

A

Datum dovoljenje:

2013-09-13

Opozorila o iskanju, povezana s tem izdelkom